Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3. J of Skin [Internet]. 2023 Mar. 13 [cited 2026 May 5];7(2):686-95. Available from: https://skin.dermsquared.com/skin/article/view/1871